News &amp; Updates

Among patients with metastatic renal cell carcinoma, there are multiple factors that affect overall survival, including race, gender, treatment, and socioeconomic factors, as reported in a study.

Overall survival in metastatic renal cell carcinoma differs by race, gender, treatment

01 Dec 2021

Folate supplementation helps increase ovarian reserve

Higher intake of folate, specifically from supplements, results in a modest increase in ovarian reserve among women, as shown in a study.

Folate supplementation helps increase ovarian reserve

Novel drug yields high clearance rate for actinic keratosis in extremities

BF-200 ALA, an investigational drug, elicits high actinic keratoses (AK) clearance rates on the trunk, neck, and extremities when used with red light photodynamic therapy (PDT), a recent study has found.

Novel drug yields high clearance rate for actinic keratosis in extremities

Poorer mental health in people with multiple psychotic experiences

01 Dec 2021 by

A recent study led by researchers from The University of Hong Kong (HKU) highlights the transient and heterogenous nature of psychotic experiences (PEs), showing that multiple PEs and the hallucination subtype of PEs may be specific indices of poor mental health condition.

Poorer mental health in people with multiple psychotic experiences

01 Dec 2021

Child abuse increased during COVID-19 lockdown

Child abuse rates appear to have increased during the lockdowns imposed to control COVID-19 transmission, according to a study from the US presented at the 2021 American Academy of Pediatrics National Conference & Exhibition (AAP 2021).

Child abuse increased during COVID-19 lockdown

30 Nov 2021

More than half of NASH patients respond to HVPG-guided NSBB prophylaxis

Hepatic venous pressure gradient (HVPG)-guided prophylaxis with non-selective beta blockers (NSBB) seems to be reasonably effective in patients with nonalcoholic steatohepatitis (NASH), eliciting responses from around half of this population, a recent study has found.

More than half of NASH patients respond to HVPG-guided NSBB prophylaxis

Cardiorenal benefit with investigational GLP-1 RA independent of concurrent SGLT2 inhibitor

The glucagon-like peptide-1 receptor agonist (GLP-1 RA) efpeglenatide affords cardiovascular and renal protection that is not explained by concurrent use of a sodium-glucose co-transporter-2 (SGLT2) inhibitor in patients with type 2 diabetes (T2D), according to an exploratory analysis of AMPLITUDE-O.

Cardiorenal benefit with investigational GLP-1 RA independent of concurrent SGLT2 inhibitor

30 Nov 2021

Childhood cancers often misdiagnosed as TB, leads to more deaths

Cancer is frequently misdiagnosed as tuberculosis (TB) in children due to the clinical and radiologic overlap of the two diseases, which then contributes to increased mortality in this population, reveals a recent study.

Childhood cancers often misdiagnosed as TB, leads to more deaths

30 Nov 2021

New chest pain guideline: Takeaways & Concerns

A new guideline on chest pain evaluation and diagnosis – touted as the first of its kind – is now out, reaping both praises and dissent from experts.

New chest pain guideline: Takeaways & Concerns

Phase II data underscores lanifibranor potential for NASH

In the phase IIb NATIVE* trial, the pan-PPAR** agonist lanifibranor demonstrated histologic benefits for patients with nonalcoholic steatohepatitis (NASH).

Phase II data underscores lanifibranor potential for NASH